Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,643Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Belmore Neidrauer LLP

02 2Blake Cassels & Graydon LLP

03 1Blake, Cassels & Graydon LLP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Abiraterone Acetate

Brand Name : ZYTIGA

Patent Number : 2132449

Filing Date : 1993-03-15

Strength per Unit : 250 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-03-15

Date Granted : 2002-09-10

blank

02

Blake, Cassels & Graydon LLP

arrow
Peptide Process CMC
Not Confirmed

Blake, Cassels & Graydon LLP

Country
arrow
Peptide Process CMC
Not Confirmed

Abiraterone Acetate

Brand Name : ZYTIGA

Patent Number : 2661422

Filing Date : 2007-08-23

Strength per Unit : 250 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2027-08-23

Date Granted : 2017-06-27

blank

03

Blake Cassels & Graydon LLP

arrow
Peptide Process CMC
Not Confirmed

Blake Cassels & Graydon LLP

Country
arrow
Peptide Process CMC
Not Confirmed

Abiraterone Acetate

Brand Name : ZYTIGA

Patent Number : 2661422

Filing Date : 2007-08-23

Strength per Unit : 500 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2027-08-23

Date Granted : 2017-06-27

blank

04

Belmore Neidrauer LLP

arrow
Peptide Process CMC
Not Confirmed

Belmore Neidrauer LLP

Country
arrow
Peptide Process CMC
Not Confirmed

Niraparib Tosylate, Abiraterone Acetate

Brand Name : AKEEGA

Patent Number : 2647545

Filing Date : 2007-04-02

Strength per Unit : 50mg / 500mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2027-04-02

Date Granted : 2016-02-23

blank

05

Belmore Neidrauer LLP

arrow
Peptide Process CMC
Not Confirmed

Belmore Neidrauer LLP

Country
arrow
Peptide Process CMC
Not Confirmed

Niraparib Tosylate, Abiraterone Acetate

Brand Name : AKEEGA

Patent Number : 2674436

Filing Date : 2008-01-08

Strength per Unit : 50mg / 500mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2028-01-08

Date Granted : 2012-07-17

blank

06

Belmore Neidrauer LLP

arrow
Peptide Process CMC
Not Confirmed

Belmore Neidrauer LLP

Country
arrow
Peptide Process CMC
Not Confirmed

Niraparib Tosylate, Abiraterone Acetate

Brand Name : AKEEGA

Patent Number : 2711491

Filing Date : 2009-01-08

Strength per Unit : 50mg / 500mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-01-08

Date Granted : 2016-03-08

blank

07

Belmore Neidrauer LLP

arrow
Peptide Process CMC
Not Confirmed

Belmore Neidrauer LLP

Country
arrow
Peptide Process CMC
Not Confirmed

Niraparib Tosylate, Abiraterone Acetate

Brand Name : AKEEGA

Patent Number : 2647545

Filing Date : 2007-04-02

Strength per Unit : 100mg / 500mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2027-04-02

Date Granted : 2016-02-23

blank

08

Belmore Neidrauer LLP

arrow
Peptide Process CMC
Not Confirmed

Belmore Neidrauer LLP

Country
arrow
Peptide Process CMC
Not Confirmed

Niraparib Tosylate, Abiraterone Acetate

Brand Name : AKEEGA

Patent Number : 2674436

Filing Date : 2008-01-08

Strength per Unit : 100mg / 500mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2028-01-08

Date Granted : 2012-07-17

blank

09

Belmore Neidrauer LLP

arrow
Peptide Process CMC
Not Confirmed

Belmore Neidrauer LLP

Country
arrow
Peptide Process CMC
Not Confirmed

Niraparib Tosylate, Abiraterone Acetate

Brand Name : AKEEGA

Patent Number : 2711491

Filing Date : 2009-01-08

Strength per Unit : 100mg / 500mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-01-08

Date Granted : 2016-03-08

blank